Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
A: Results may vary depending on the individuals skin type and condition
What makes Zepbound unique is that it is not just a GLP-1 receptor agonist
The primary reason for the raise in the guidance on the revenue is related to the GLP-1, Alt said in the earnings call
From artificial food dyes to weight-loss injections, there is often a disconnect between what people consume and their understanding of its digestive impact
Develop a documented rotation schedule that moves your injection site at least one inch away from the previous location each week